text
"['\n1. 요약재무정보\n가. 요약연결재무정보\n(단위 : 백만원)\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 사업연도구 \xa0분\n제44기\n제43기\n제42기\n[유동자산]\n365,030\n386,120\n411,302\n- 당좌자산\n227,630\n260,713\n311,060\n- 재고자산\n125,347\n125,407\n100,242\n- 기타유동자산\n-\n-\n-\n[비유동자산]\n940,956\n867,191\n785,873\n- 유형자산\n755,957\n691,561\n625,128\n- 사용권자산\n7,341\n7,373\n5,710\n- 무형자산\n79,055\n65,952\n66,564\n- 기타비유동자산\n98,603\n102,305\n88,470\n자산총계\n1,293,933\n1,253,311\n1,197,175\n[유동부채]\n244,527\n153,670\n199,712\n[비유동부채]\n153,848\n247,144\n229,593\n부채총계\n398,375\n400,814\n429,305\n[자본금]\n56,676\n56,676\n56,676\n[자본잉여금]\n29,840\n30,012\n30,012\n[기타자본구성요소]\n(43,230)\n(47,755)\n11,801\n[기타포괄손익누계액]\n(9,445)\n(9,348)\n(5,107)\n[이익잉여금]\n768,207\n733,897\n595,858\n[비지배지분]\n93,511\n89,015\n78,630\n자본총계\n895,559\n852,497\n767,870\n종속ㆍ관계ㆍ공동기업 투자주식의 평가방법\n원가법\n원가법\n원가법\n(2023.01.01~2023.06.30)\n(2022.01.01~2022.12.31)\n(2021.01.01~2021.12.31)\n매출액\n391,905\n885,471\n768,688\n영업이익\n287,897\n185,990\n197,685\n당기순이익\n59,769\n166,978\n158,671\n지배회사지분순이익\n57,077\n155,127\n148,338\n주당순이익\n\xa0기본주당이익\n5,247원\n14,099원\n13,332원\n\xa0희석주당이익\n5,205원\n14,021원\n13,331원\n연결에 포함된 회사수\n7\n6\n6\n* 당기 중 (주)바이옥스 지분 취득으로 연결대상 종속회사가 증가하였습니다.나. 요약재무정보\n(단위 : 백만원)\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 사업연도구 \xa0분\n제44기\n제43기\n제42기\n[유동자산]\n250,324\n252,085\n310,019\n- 당좌자산\n165,817\n162,584\n236,056\n- 재고자산\n84,507\n89,501\n73,963\n[비유동자산]\n769,082\n716,932\n637,498\n- 유형자산\n629,987\n592,075\n522,522\n- 무형자산\n5,773\n4,287\n4,310\n- 사용권자산\n1,454\n1,670\n1,786\n- 기타비유동자산\n131,868\n118,900\n108,880\n자산총계\n1,019,406\n969,017\n947,517\n[유동부채]\n184,865\n102,165\n164,963\n[비유동부채]\n126,209\n216,524\n173,271\n부채총계\n311,074\n318,689\n338,234\n[자본금]\n56,676\n56,676\n56,676\n[자본잉여금]\n29,928\n29,928\n29,928\n[자본조정]\n(43,443)\n(47,968)\n11,722\n[기타포괄손익누계액]\n(9,158)\n(8,841)\n(8,365)\n[이익잉여금]\n674,329\n620,533\n519,322\n자본총계\n708,332\n650,328\n609,283\n종속ㆍ관계ㆍ공동기업 투자주식의 평가방법\n원가법\n원가법\n원가법\n(2023.01.01~2023.06.30)\n(2022.01.01~2022.12.31)\n(2021.01.01~2021.12.31)\n매출액\n284.647\n637,647\n570,246\n영업이익\n56,255\n145,266\n166,023\n당기순이익\n76,564\n120,840\n130,175\n주당순이익\n\xa0기본주당이익\n7,038원\n10,983원\n11,700원\n\xa0희석주당이익\n6,982원\n10,929원\n11,698원\n']"
